查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1190546

牙科骨基質市場——增長、趨勢、COVID-19 的影響和預測 (2023-2028)

Dental Bone Graft Substitutes Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在 2022 年至 2027 年的預測期內，牙科骨替代材料市場預計將以 6.8% 的複合年增長率增長。

COVID-19 大流行正在影響世界各地的行業。 由於所有從事 COVID-19 管理的醫療機構只能獲得基本護理，牙科診所的臨時關閉大大減少了牙科手術。 例如，美國牙科協會 (ADA) 已將選擇性牙科護理推遲至 2020 年 4 月 6 日，並建議牙科診所僅提供緊急牙科服務。 此外，在 2020 年 4 月 1 日的更新中，ADA 建議，由於 COVID-19 病例數量不斷增加，至少在 4 月 30 日之前應避免非緊急和急救程序。增加。 結果，獲得牙科保健的機會大大減少。 此外，2020 年 3 月，根據 ADA 健康政策研究所的一項調查，76% 的受訪牙科診所關閉且僅關閉急診患者，19% 完全關閉，5% 開放，但患者數量很小 這就是我所說的。 這些因素嚴重影響了牙科骨替代品製造商及其供應鏈。 因此，這些統計數據表明，在 COVID-19 大流行期間，對牙科骨替代材料的需求有所下降。

此外，醫療和牙科旅遊需求的增加、牙科疾病負擔的增加以及牙科技術的進步是市場增長的主要驅動力。 牙科疾病負擔的增加正在推動市場的增長。 例如，根據世界衛生組織（2020 年）的數據，口腔疾病影響了大約 35 億人，據說超過 5.3 億兒童的乳牙患有齲齒。

在植入種植體之前進行植骨以維持現有的頜骨，這有助於種植體手術的成功。 因此，在牙科手術中越來越多地使用這種合成和生物相容的植入物最終將引發市場增長。 2020 年 5 月發表的一項題為“全球牙周病患病率及其缺乏監測”的研究發現，牙周炎在老年人和高收入人群中最為常見。 低收入（28.7%）、中低收入（10%）、中高收入（42.5%）和高收入（43.7%）國家之間的分配差異很大。 此外，根據 International Dental Journal 論文“墨西哥成年人群中牙齒脫落的風險指標”，“墨西哥成年人群中牙齒缺失的風險指標。”2021 年 2 月發表的一項橫斷面研究。57.2% 的牙齒是在墨西哥因齲齒而失蹤。 因此，由於上述因素，預計未來市場將出現顯著增長。

此外，市場參與者的戰略舉措也在推動市場的增長。 例如，2022 年 4 月，Aspen Group 與骨再生產品供應商之一的 ACE Surgical Supply 就牙科植骨解決方案建立了多年戰略合作夥伴關係。

因此，由於上述因素，市場預計在預測期內會出現增長。 然而，昂貴的牙科治療和保險報銷問題阻礙了市場增長。

主要市場趨勢

異種移植部分預計在預測期內增長

按類型劃分，異種移植部分預計將佔據很大的市場份額。 異種移植是將器官或組織移植到另一個物種的個體中。 異種移植物是從豬 (pigs) 或牛 (bovines) 獲得的，經過大量清潔和滅菌後準備用於人體植入。 脫蛋白牛骨是牙科中最常見的異種移植物來源。 市售的異種移植物包括 Bio-Oss、Bio-Oss 膠原蛋白和 Pepgen-P15。 由於異種移植是最便宜的，市場上的主要參與者都在努力推出新產品。

例如，2022 年 3 月，Fredun Pharmaceuticals Limited 獲得印度中央藥品標準控制組織 (CDSCO) 的批准，可以為一系列牙科和骨科手術器械製造異種移植物。 有了這個，該公司的目標是滲透到整個印度的牙科社區。 這些發展有望加速牙科骨替代品的發展，以取代異種移植物並促進該領域的發展。

此外，市場參與者的戰略舉措也為市場的增長做出了貢獻。 例如，2021 年 9 月，Neos 與 Pergo Biologics 簽署了一項協議，成為德國、瑞典和英國市場 Pergo Xenograft 牙種植體解決方案的主要合作夥伴和分銷商。

因此，由於上述因素，預計該行業在預測期內將出現顯著增長。

北美主導市場，預計在預測期內也會如此

牙科骨替代材料的全球市場預計將由北美主導。 在北美地區，美國有望佔據較大的市場份額。 促進市場增長的主要因素是市場參與者採取的戰略舉措和牙科就診次數的增加。

例如，根據疾病控制與預防中心 (CDC) 於 2021 年 1 月更新的數據，四分之一的 20-64 歲成年人至少有一顆蛀牙，大約 57% 的 12-64 歲青少年據說19年打了恆牙。 此外，根據 CDC（美國疾病控制與預防中心）2020 年 12 月的統計數據，超過四分之一的成年人 (26%) 有未經治療的蛀牙，30 歲以上的成年人中約有一半 (46%) ) 顯示出牙周病的跡象，嚴重的牙周病影響了美國大約 9% 的成年人。 據稱，美國約有 9% 的成年人患有嚴重的牙周病。 根據這些統計數據，人們認為接受牙科護理的人口比例正在促進市場的增長。

此外，產品發布、批准、收購、合併、合作夥伴關係和合資企業等一系列戰略舉措有望促進該地區的增長，例如。 例如，2021 年 1 月，Dentsply Sirona 收購了以創新牙科修復產品而聞名的 Datum Dental Ltd.。 通過此次收購，登士柏西諾德在美國、加拿大和其他幾個國家推廣了完整的 OSSIX 產品組合，包括 OSSIX Plus、OSSIX Volumax 和 OSSIX Bone。

因此，由於上述因素，預計市場在預測期內將出現顯著增長。

競爭格局

牙科骨替代品市場是一個競爭激烈的市場，在世界不同地區有多家公司。 從市場份額的角度來看，一些重要的參與者目前主導著市場。 隨著患者意識水平的提高和牙科疾病的高患病率，預計許多區域參與者將在預測期內主導牙科骨替代品市場。 市場上的主要參與者包括 Dentsply Sirona、Johnson & Johnson、Institut Straumann AG、Medtronic PLC 和 ZIMMER BIOMET。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 對醫療、牙科和旅遊的需求增加
    • 牙科疾病負擔增加
    • 技術進步
  • 市場製約因素
    • 昂貴的牙科治療
    • 保險報銷問題
  • 產業吸引力 - 波特五力分析
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按類型
    • 異種移植
    • 同種異體移植
    • 自體移植
    • 其他類型
  • 按機制
    • 骨傳導
    • 骨誘導（骨誘導
    • 骨骼形成
    • 促進骨質疏鬆
  • 最終用戶
    • 醫院
    • 牙科診所
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Dentsply Sirona
    • Johnson & Johnson
    • Institut Straumann AG
    • Medtronic PLC
    • ZIMMER BIOMET
    • Geistlich Pharm
    • Dentium
    • LifeNet Health
    • Collagen Matrix Inc.
    • Halma plc（Novabone LLC）
    • Botiss biomaterials GmbH
    • Wright Medical Group NV

第7章 市場機會今後動向

簡介目錄
Product Code: 72108

The dental bone graft substitutes market is expected to witness a CAGR of 6.8% over the forecast period, 2022-2027.

The COVID-19 pandemic has impacted industries worldwide. As all healthcare providers were engaged with COVID-19 management, access was restricted to essential care only, and the temporary closure of dental clinics drastically reduced dental surgeries. For instance, the American Dental Association (ADA) recommended that elective dental procedures be postponed until April 6, 2020, and dental practices should provide emergency-only dental services. Additionally, as per April 1, 2020, update, the ADA advised offices to remain closed to all but urgent and emergency procedures until April 30, at the earliest, owing to increasing COVID-19 cases. As a result, access to dental care was substantially decreased. Moreover, in March 2020, an ADA health policy institute survey indicated that 76% of dental offices surveyed were closed but seeing emergency patients only, 19% were completely closed, and 5% were open but seeing a lower volume of patients. These factors severely impacted dental bone graft substitute manufacturers and their supply chains. Thus, these statistics indicate that the demand for dental bone graft substitutes was reduced during the COVID-19 pandemic.

Furthermore, the significant factors responsible for the market's growth include the rising demand for medical and dental tourism; the increasing burden of dental diseases; and technological advancements in dentistry. The rising burden of dental diseases is driving the market's growth. For instance, according to the World Health Organization (2020), oral diseases affect nearly 3.5 billion people, and over 530 million children suffer from caries of their primary teeth.

To maintain the existing jaw, bone grafting is done before implant placement, which helps with successful implant surgery. Thus, increasing the use of such synthetic and biocompatible grafts in dental procedures ultimately triggers the market's growth. As per a May 2020 published study titled "Global Prevalence of Periodontal Disease and Lack of Its Surveillance," periodontitis was most common in older people and populations from high-income countries. The distribution varied significantly between low-income (28.7%), lower-middle (10%), upper-middle (42.5%), and high-income (43.7%) countries. Additionally, according to the International Dental Journal's article titled, "Risk Indicators of Tooth Loss among the Mexican Adult Population: A Cross-Sectional Study," published in February 2021, tooth loss was 57.2% due to tooth decay in Mexico. Hence, owing to the aforementioned factors, the market is expected to witness significant growth in the future.

Additionally, the strategic initiatives taken by the market players are also propelling the growth of the market. For instance, in April 2022, the Aspen Group and ACE Surgical Supply, one of the providers of bone regenerative products, signed a multi-year strategic partnership for dental bone grafting solutions.

Thus, owing to the abovementioned factors, the market is expected to show growth over the forecast period. However, expensive dental procedures and reimbursement issues hinder the market's growth.

Key Market Trends

The Xenogaft Segment is Expected to Grow Over the Forecast Period

The xenograft segment is expected to hold a significant market share by type. A xenograft is an organ transplant or a tissue graft to an individual of another species. Xenografts are obtained from pigs (porcine) or cows (bovine) and are prepared for implantation into the human body once thoroughly cleaned and sterilized. Deproteinized bovine bone is the most common source of xenograft materials in dentistry. A few commercially available xenografts are Bio-Oss, Bio-Oss Collagen, and Pepgen-P15, among others. As xenograft are most affordable, the key players in the market are taking initiatives to launch new products.

For instance, in March 2022, Fredun Pharmaceuticals Limited received approval to manufacture Xenografts for various dental and orthopedic surgical appliances from the Central Drugs Standard Control Organisation (CDSCO), India. With this, the company aims to penetrate the dental fraternity across India. Such developments are expected to fuel the development of dental bone graft substitutes for xenografts, thereby boosting the segment's growth.

Additionally, the strategic initiatives taken by the market players are also contributing to the growth of the market. For instance, in September 2021, Neoss signed an agreement with Purgo Biologics and became a key partner and distributor of the Purgo Xenograft product range for dental implant solutions in the German, Swedish, and United Kingdom markets.

Thus, the segment is expected to witness significant growth over the forecast period due to the abovementioned factors.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the global dental bone graft substitutes market. United States is likely to hold a significant market share in the North American region. The major factors contributing to the market's growth are strategic initiatives undertaken by the market players and the growing number of dental visits.

For instance, according to the Centers for Disease Control and Prevention (CDC) data updated in January 2021, 1 in 4 adults between 20-64 years of age suffer from at least one cavity, and almost 57% of adolescents aged 12-19 have had a hole in their permanent teeth. Also, as per December 2020 statistics by the Centers for Disease Control and Prevention (CDC), more than 1 in 4 (26%) adults have untreated tooth decay, and nearly half (46%) of all adults aged 30 years or older show signs of gum disease; and severe gum disease affects about 9% of adults in United States. These statistics indicate that the percentage of the population visiting dental clinics for examinations contributes to the market's growth.

Moreover, the growing number of strategic initiatives such as product launches, approvals, acquisitions, mergers, partnerships, and joint ventures are anticipated to boost regional growth. For instance, Dentsply Sirona acquired Datum Dental Ltd., known for innovative dental regeneration products, in January 2021. With this acquisition, Dentsply Sirona promotes the complete OSSIX portfolio, including OSSIX Plus, OSSIX Volumax, and OSSIX Bone, in United States, Canada, and several other countries.

Thus, the market is expected to witness significant growth over the forecast period due to the abovementioned factors.

Competitive Landscape

The dental bone graft substitutes market is highly competitive, with several players worldwide. In terms of market share, few significant players currently dominate the market. With the rising patient awareness levels and high prevalence of dental disorders, many regional players are expected to be part of the dental bone graft substitute market over the forecast period. Some of the market's major players are Dentsply Sirona, Johnson & Johnson, Institut Straumann AG, Medtronic PLC, ZIMMER BIOMET, etc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Demand of Medical and Dental Tourism
    • 4.2.2 Rising Burden of Dental Diseases
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Expensive Dental Procedures
    • 4.3.2 Reimbursement Issues
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Buyers/Consumers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Xenograft
    • 5.1.2 Allograft
    • 5.1.3 Autograft
    • 5.1.4 Other Types
  • 5.2 By Mechanism
    • 5.2.1 Osteoconduction
    • 5.2.2 Osteoinduction
    • 5.2.3 Osteogenesis
    • 5.2.4 Osteopromotion
  • 5.3 By End Users
    • 5.3.1 Hospitals
    • 5.3.2 Dental Clinics
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Dentsply Sirona
    • 6.1.2 Johnson & Johnson
    • 6.1.3 Institut Straumann AG
    • 6.1.4 Medtronic PLC
    • 6.1.5 ZIMMER BIOMET
    • 6.1.6 Geistlich Pharm
    • 6.1.7 Dentium
    • 6.1.8 LifeNet Health
    • 6.1.9 Collagen Matrix Inc.
    • 6.1.10 Halma plc (Novabone LLC)
    • 6.1.11 Botiss biomaterials GmbH
    • 6.1.12 Wright Medical Group NV

7 MARKET OPPORTUNITIES AND FUTURE TRENDS